Evidence map›Paper›PMID 25136830›Full record

ArticlePloS one2014

Characterization of the regulatory mechanisms of activating transcription factor 3 by hypertrophic stimuli in rat cardiomyocytes.

Elina Koivisto, Alicia Jurado Acosta, Anne-Mari Moilanen, Heikki Tokola, Jani Aro, Harri Pennanen, Hanna Säkkinen, Leena Kaikkonen, Heikki Ruskoaho, Jaana Rysä

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Prostaglandin EThe Journal of biological chemistry · 2019
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Elina KoivistoDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland.
Alicia Jurado AcostaDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland.
Anne-Mari MoilanenDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland; Department of Pathology, Institute of Diagnostics, University of Oulu, Oulu, Finland.
Heikki TokolaDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland; Department of Pathology, Institute of Diagnostics, University of Oulu, Oulu, Finland.
Jani AroDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland.
Harri PennanenDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland.
Hanna SäkkinenDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland.
Leena KaikkonenDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland.
Heikki RuskoahoDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Jaana RysäDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland; School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
University of Oulu · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsActivating transcription factor 3 (ATF3) is a stress-activated immediate early gene suggested to have both detrimental and cardioprotective role in the heart. Here we studied the mechanisms of ATF3 activation by hypertrophic stimuli and ATF3 downstream targets in rat cardiomyocytes. METHODS AND

resultsWhen neonatal rat cardiomyocytes were exposed to endothelin-1 (ET-1, 100 nM) and mechanical stretching in vitro, maximal increase in ATF3 expression occurred at 1 hour. Inhibition of extracellular signal-regulated kinase (ERK) by PD98059 decreased ET-1- and stretch-induced increase of ATF3 protein but not ATF3 mRNA levels, whereas protein kinase A (PKA) inhibitor H89 attenuated both ATF3 mRNA transcription and protein expression in response to ET-1 and stretch. To characterize further the regulatory mechanisms upstream of ATF3, p38 mitogen-activated protein kinase (MAPK) signaling was investigated using a gain-of-function approach. Adenoviral overexpression of p38α, but not p38β, increased ATF3 mRNA and protein levels as well as DNA binding activity. To investigate the role of ATF3 in hypertrophic process, we overexpressed ATF3 by adenovirus-mediated gene transfer. In vitro, ATF3 gene delivery attenuated the mRNA transcription of interleukin-6 (IL-6) and plasminogen activator inhibitor-1 (PAI-1), and enhanced nuclear factor-κB (NF-κB) and Nkx-2.5 DNA binding activities. Reduced PAI-1 expression was also detected in vivo in adult rat heart by direct intramyocardial adenovirus-mediated ATF3 gene delivery.

conclusionsThese data demonstrate that ATF3 activation by ET-1 and mechanical stretch is partly mediated through ERK and cAMP-PKA pathways, whereas p38 MAPK pathway is involved in ATF3 activation exclusively through p38α isoform. ATF3 activation caused induction of modulators of the inflammatory response NF-κB and Nkx-2.5, as well as attenuation of pro-fibrotic and pro-inflammatory proteins IL-6 and PAI-1, suggesting cardioprotective role for ATF3 in the heart.

Indexed as

Activating Transcription Factor 3AnimalsBiomechanical PhenomenaCardiomyopathy, HypertrophicCells, CulturedEndothelin-1FemaleHomeobox Protein Nkx-2.5Homeodomain ProteinsInflammation MediatorsIsoenzymesMaleMyocytes, CardiacNF-kappa Bp38 Mitogen-Activated Protein KinasesPlasminogen Activator Inhibitor 1Activating Transcription Factor 3Atf3 protein, ratEndothelin-1Homeobox Protein Nkx-2.5Homeodomain ProteinsInflammation MediatorsIsoenzymesNF-kappa BNkx2-5 protein, ratp38 Mitogen-Activated Protein KinasesPlasminogen Activator Inhibitor 1Protein Kinase InhibitorsTranscription Factors

Identifiers

PMID25136830
PMCPMC4138181
OpenAlexW2061865489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.